Analyst Consensus ?
ConsensusHold23 ratings
Bullish1147.8%
Neutral1147.8%
Bearish14.4%
FN2 Earnings Intelligence
Ameren Corporation (AEE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Sector Weight | Upgrade | Jul 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Argus Research | Buy | Buy | Maintain | Mar 23, 2026 |
| UBS | Buy | Buy | Maintain | Feb 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 13, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 27, 2025 |
| Goldman Sachs | Neutral | Sell | Upgrade | Jun 25, 2025 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 21, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Aug 29, 2024 |
| Guggenheim | Neutral | Neutral | Maintain | Jul 7, 2023 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 16, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Sep 17, 2019 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 12, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Wunderlich Securities | Hold | Hold | Maintain | May 3, 2013 |
| Wunderlich | Hold | Hold | Maintain | May 3, 2013 |
| Edward Jones | Hold | Sell | Upgrade | Dec 24, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | May 8, 2012 |
| ISI Group | Hold | Hold | Maintain | Apr 12, 2012 |
Upside is calculated against the persisted current price $109.37. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Analyst unavailable | $126 | $112.01 | +15.2% | Jul 23, 2026 |
| KeyBanc | Analyst unavailable | $122 | $112.01 | +11.5% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $118 | $111.36 | +7.9% | Jul 22, 2026 |
| Barclays | Nicholas Campanella | $117 | $112.54 | +7.0% | Jul 9, 2026 |
| Morgan Stanley | David Arcaro | $115 | $112.71 | +5.1% | Jun 24, 2026 |
| Morgan Stanley | Analyst unavailable | $110 | $109.74 | +0.6% | May 21, 2026 |
| Morgan Stanley | David Arcaro | $117 | $110.68 | +7.0% | Apr 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $120 | $111.27 | +9.7% | Apr 21, 2026 |
| Truist Financial | Richard Sunderland | $126 | $111.27 | +15.2% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $116 | $111.86 | +6.1% | Apr 15, 2026 |
| BTIG | Alex Kania | $131 | $114.32 | +19.8% | Apr 9, 2026 |
| Morgan Stanley | David Arcaro | $116 | $109.46 | +6.1% | Feb 20, 2026 |
| UBS | William Appicelli | $127 | $109.31 | +16.1% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $113 | $109.4 | +3.3% | Feb 13, 2026 |
| Mizuho Securities | Analyst unavailable | $117 | $109.34 | +7.0% | Feb 13, 2026 |
| BMO Capital | Analyst unavailable | $120 | $109.34 | +9.7% | Feb 13, 2026 |
| RBC Capital | Stephen D'Ambrisi | $116 | $101.85 | +6.1% | Jan 23, 2026 |
| Morgan Stanley | David Arcaro | $108 | $103.75 | -1.3% | Jan 21, 2026 |
| Wells Fargo | Analyst unavailable | $111 | $104 | +1.5% | Jan 20, 2026 |
| Barclays | Nicholas Campanella | $104 | $102.54 | -4.9% | Jan 15, 2026 |
| UBS | Analyst unavailable | $115 | $97.99 | +5.1% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $103 | $98.87 | -5.8% | Dec 16, 2025 |
| Wells Fargo | Analyst unavailable | $112 | $104.81 | +2.4% | Oct 27, 2025 |
| RBC Capital | Stephen D'Ambrisi | $119 | $104.81 | +8.8% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $114 | $104.18 | +4.2% | Oct 27, 2025 |
| Morgan Stanley | Analyst unavailable | $111 | $105.38 | +1.5% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $111 | $104.92 | +1.5% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $113 | $105.69 | +3.3% | Oct 21, 2025 |
| KeyBanc | Analyst unavailable | $109 | $104.23 | -0.3% | Oct 15, 2025 |
| Morgan Stanley | David Arcaro | $104 | $101.13 | -4.9% | Sep 25, 2025 |
| KeyBanc | Sophie Karp | $104 | $96.46 | -4.9% | Jul 16, 2025 |
| UBS | William Appicelli | $114 | $96.2 | +4.2% | Jul 11, 2025 |
| Goldman Sachs | Carly Davenport | $100 | $95.1 | -8.6% | Jun 25, 2025 |
| Morgan Stanley | David Arcaro | $102 | $95.4 | -6.7% | May 22, 2025 |
| KeyBanc | Sophie Karp | $103 | $95.42 | -5.8% | May 14, 2025 |
| Barclays | Analyst unavailable | $102 | $100 | -6.7% | Mar 4, 2025 |
| Jefferies | Julien Dumoulin-Smith | $97 | $83.62 | -11.3% | Sep 19, 2024 |
| Mizuho Securities | Anthony Crowdel | $89 | $83.99 | -18.6% | Sep 16, 2024 |
| BMO Capital | James Thalacker | $87 | $80.85 | -20.5% | Aug 6, 2024 |
| UBS | Daniel Ford | $87 | $74.82 | -20.5% | Jul 19, 2024 |
| BMO Capital | James Thalacker | $80 | $71.13 | -26.9% | Jun 21, 2024 |
| Barclays | Nicholas Campanella | $77 | $70.1 | -29.6% | May 30, 2024 |
| Goldman Sachs | Carly Davenport | $73 | $74.9 | -33.3% | May 16, 2024 |
| BMO Capital | James Thalacker | $81 | $73.85 | -25.9% | May 6, 2024 |
| Wells Fargo | Neil Kalton | $94 | $78.55 | -14.1% | Oct 19, 2023 |
| Barclays | Eric Beaumont | $80 | $77.43 | -26.9% | Sep 5, 2023 |
| KeyBanc | Sophie Karp | $90 | $83.36 | -17.7% | Jun 11, 2023 |
| Morgan Stanley | Analyst unavailable | $92 | $88.16 | -15.9% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $86 | $84.86 | -21.4% | Nov 11, 2022 |
| Mizuho Securities | Anthony Crowdell | $92 | $88.24 | -15.9% | Jul 8, 2022 |
| Argus Research | Analyst unavailable | $102 | $93.73 | -6.7% | Jun 3, 2022 |
| Argus Research | Analyst unavailable | $112 | $96.36 | +2.4% | May 26, 2022 |
| Mizuho Securities | Analyst unavailable | $98 | $95.8 | -10.4% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $104 | $95.92 | -4.9% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $101 | $97.75 | -7.7% | Apr 20, 2022 |
| Argus Research | Gary Hovis | $90 | $79.7 | -17.7% | Jun 24, 2021 |
| Bank of America Securities | Julien Dumoulin Smith | $89 | $81.8 | -18.6% | Jun 21, 2021 |
| Goldman Sachs | Insoo Kim | $90 | $84.49 | -17.7% | Jun 15, 2021 |
Track every rating change on AEE the moment it posts. Free to start.
Start free